Display options
Cite
Brinkmann K, Schell M, Hoppe T, et al. Regulation of the DNA damage response by ubiquitin conjugation. Front Genet. 2015;6:98doi: 10.3389/fgene.2015.00098.
Brinkmann, K., Schell, M., Hoppe, T., & Kashkar, H. (2015). Regulation of the DNA damage response by ubiquitin conjugation. Frontiers in genetics, 698. https://doi.org/10.3389/fgene.2015.00098
Brinkmann, Kerstin, et al. "Regulation of the DNA damage response by ubiquitin conjugation." Frontiers in genetics vol. 6 (2015): 98. doi: https://doi.org/10.3389/fgene.2015.00098
Brinkmann K, Schell M, Hoppe T, Kashkar H. Regulation of the DNA damage response by ubiquitin conjugation. Front Genet. 2015 Mar 10;6:98. doi: 10.3389/fgene.2015.00098. eCollection 2015. PMID: 25806049; PMCID: PMC4354423.
Copy Download .nbib Format: NLM
Share it on

Front Genet. 2015 Mar 10;6:98. doi: 10.3389/fgene.2015.00098. eCollection 2015.

Regulation of the DNA damage response by ubiquitin conjugation.

Frontiers in genetics

Kerstin Brinkmann, Michael Schell, Thorsten Hoppe, Hamid Kashkar

Affiliations

  1. Centre for Molecular Medicine Cologne and Institute for Medical Microbiology, Immunology and Hygiene, University Hospital of Cologne Cologne, Germany ; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University Hospital of Cologne Cologne, Germany.
  2. Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University Hospital of Cologne Cologne, Germany ; Institute for Genetics, University of Cologne Cologne, Germany.

PMID: 25806049 PMCID: PMC4354423 DOI: 10.3389/fgene.2015.00098

Abstract

In response to DNA damage, cells activate a highly conserved and complex kinase-based signaling network, commonly referred to as the DNA damage response (DDR), to safeguard genomic integrity. The DDR consists of a set of tightly regulated events, including detection of DNA damage, accumulation of DNA repair factors at the site of damage, and finally physical repair of the lesion. Upon overwhelming damage the DDR provokes detrimental cellular actions by involving the apoptotic machinery and inducing a coordinated demise of the damaged cells (DNA damage-induced apoptosis, DDIA). These diverse actions involve transcriptional activation of several genes that govern the DDR. Moreover, recent observations highlighted the role of ubiquitylation in orchestrating the DDR, providing a dynamic cellular regulatory circuit helping to guarantee genomic stability and cellular homeostasis (Popovic et al., 2014). One of the hallmarks of human cancer is genomic instability (Hanahan and Weinberg, 2011). Not surprisingly, deregulation of the DDR can lead to human diseases, including cancer, and can induce resistance to genotoxic anti-cancer therapy (Lord and Ashworth, 2012). Here, we summarize the role of ubiquitin-signaling in the DDR with special emphasis on its role in cancer and highlight the therapeutic value of the ubiquitin-conjugation machinery as a target in anti-cancer treatment strategy.

Keywords: Bcl-2; DNA damage; apoptosis; genotoxic anti-cancer therapy; p53; ubiquitylation

References

  1. Annu Rev Biochem. 1999;68:1015-68 - PubMed
  2. Cell Death Differ. 2006 Jun;13(6):951-61 - PubMed
  3. Cell. 1984 May;37(1):57-66 - PubMed
  4. Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12753-8 - PubMed
  5. Nature. 2012 Jan 18;481(7381):287-94 - PubMed
  6. Cell. 1999 Mar 5;96(5):635-44 - PubMed
  7. Breast Cancer Res Treat. 1996;37(2):179-88 - PubMed
  8. J Biol Chem. 2011 Jun 3;286(22):19331-9 - PubMed
  9. J Biol Chem. 2000 Jul 14;275(28):21648-52 - PubMed
  10. Nat Med. 2005 Nov;11(11):1135-6; author reply 1136-7 - PubMed
  11. Cell Cycle. 2005 Sep;4(9):1166-70 - PubMed
  12. Cell Death Dis. 2012 Nov 15;3:e419 - PubMed
  13. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):3850-5 - PubMed
  14. EMBO J. 2003 Dec 15;22(24):6653-64 - PubMed
  15. Oncogene. 2013 Nov 28;32(48):5439-48 - PubMed
  16. Annu Rev Biochem. 1998;67:425-79 - PubMed
  17. Nucleic Acids Res. 1998 Aug 1;26(15):3453-9 - PubMed
  18. Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7818-23 - PubMed
  19. Nat Rev Cancer. 2006 May;6(5):382-91 - PubMed
  20. Cancer Res. 2006 Jun 15;66(12):6353-60 - PubMed
  21. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14973-7 - PubMed
  22. Mol Cell Biol. 2003 Aug;23 (15):5113-21 - PubMed
  23. Cancer. 2009 Oct 1;115(19):4554-63 - PubMed
  24. Nature. 2004 May 6;429(6987):86-92 - PubMed
  25. Nature. 1993 Apr 29;362(6423):849-52 - PubMed
  26. J Biol Chem. 2003 Oct 3;278(40):38315-24 - PubMed
  27. Cancer Cell. 2002 Jul;2(1):9-15 - PubMed
  28. Nat Med. 2004 Dec;10 (12 ):1321-8 - PubMed
  29. Cell Death Dis. 2014 Mar 06;5:e1098 - PubMed
  30. Science. 2000 May 12;288(5468):1053-8 - PubMed
  31. J Biol Chem. 2011 Jul 8;286(27):23725-34 - PubMed
  32. J Exp Med. 1999 Jun 7;189(11):1815-22 - PubMed
  33. EMBO J. 2011 Jun 1;30(11):2177-89 - PubMed
  34. Oncol Rep. 2013 Oct;30(4):1971-5 - PubMed
  35. Cancer Cell. 2002 Sep;2(3):183-92 - PubMed
  36. Nature. 2009 May 21;459(7245):460-3 - PubMed
  37. Cell Death Differ. 2013 Feb;20(2):281-92 - PubMed
  38. EMBO J. 2011 Mar 2;30(5):846-58 - PubMed
  39. Science. 1998 Sep 11;281(5383):1674-7 - PubMed
  40. Blood. 1993 Nov 1;82(9):2617-23 - PubMed
  41. Oncogene. 1999 Jul 8;18(27):3923-9 - PubMed
  42. Mol Cell. 2001 Mar;7(3):683-94 - PubMed
  43. EMBO J. 2005 Feb 23;24(4):836-48 - PubMed
  44. Cell. 2010 Feb 5;140(3):384-96 - PubMed
  45. Mol Cancer Ther. 2005 Mar;4(3):443-9 - PubMed
  46. Biochem J. 1993 Dec 15;296 ( Pt 3):737-44 - PubMed
  47. Oncogene. 2012 Nov 8;31(45):4789-97 - PubMed
  48. Cell Death Differ. 2005 Sep;12 (9):1225-39 - PubMed
  49. Mol Cell. 2011 Mar 4;41(5):609-15 - PubMed
  50. Cell Death Differ. 2013 Jun;20(6):812-22 - PubMed
  51. Mol Cell Biol. 2007 Jun;27(11):4006-17 - PubMed
  52. EMBO J. 2007 Feb 21;26(4):976-86 - PubMed
  53. Nucleic Acids Res. 1994 Sep;22(17):3551-5 - PubMed
  54. Nat Rev Mol Cell Biol. 2013 Apr;14(4):197-210 - PubMed
  55. Oncogene. 2005 Nov 3;24(48):7156-69 - PubMed
  56. J Biol Chem. 1983 Jul 10;258(13):8206-14 - PubMed
  57. Nat Struct Mol Biol. 2006 Mar;13(3):285-91 - PubMed
  58. Cell Cycle. 2008 Jun 1;7(11):1604-12 - PubMed
  59. J Biol Chem. 2011 Oct 14;286(41):35388-95 - PubMed
  60. Cancer Chemother Pharmacol. 2011 Aug;68(2):513-24 - PubMed
  61. Nat Med. 2011 Mar;17 (3):347-55 - PubMed
  62. DNA Repair (Amst). 2010 Dec 10;9(12 ):1229-40 - PubMed
  63. Nature. 1993 Apr 29;362(6423):847-9 - PubMed
  64. Cancer Res. 2004 Nov 15;64(22):8152-5 - PubMed
  65. Cancer Res. 2004 Oct 15;64(20):7226-30 - PubMed
  66. PLoS One. 2012;7(1):e29783 - PubMed
  67. EMBO J. 2012 Apr 18;31(8):1865-78 - PubMed
  68. Cell Signal. 2010 May;22(5):801-8 - PubMed
  69. J Biol Chem. 2003 Nov 14;278(46):45946-53 - PubMed
  70. Int J Mol Sci. 2012;13(5):6204-19 - PubMed
  71. Hepatogastroenterology. 2005 Nov-Dec;52(66):1854-7 - PubMed
  72. Cell. 2005 Jul 1;121(7):1085-95 - PubMed
  73. Nature. 1995 Jan 5;373(6509):81-3 - PubMed
  74. Nature. 2010 Jun 17;465(7300):951-5 - PubMed
  75. Int J Oncol. 2002 Sep;21(3):499-507 - PubMed
  76. Oncogene. 2008 Dec;27 Suppl 1:S149-57 - PubMed
  77. Nat Struct Mol Biol. 2011 Nov 27;18(12 ):1345-50 - PubMed
  78. EMBO Rep. 2008 Oct;9(10 ):990-7 - PubMed
  79. Clin Cancer Res. 2008 Mar 15;14(6):1649-57 - PubMed
  80. Am J Physiol. 1997 Oct;273(4 Pt 2):F575-85 - PubMed
  81. Cell. 2011 Mar 4;144(5):646-74 - PubMed
  82. Cell Death Differ. 2008 May;15(5):841-8 - PubMed
  83. FEBS Lett. 2011 Sep 16;585(18):2868-75 - PubMed
  84. Nat Struct Mol Biol. 2008 Dec;15(12 ):1334-42 - PubMed
  85. PLoS Comput Biol. 2011 Dec;7(12):e1002279 - PubMed
  86. Cell. 1994 Oct 21;79(2):329-39 - PubMed
  87. Carcinogenesis. 2012 Aug;33(8):1581-8 - PubMed
  88. J Biol Chem. 2002 Dec 20;277(51):49668-75 - PubMed
  89. Nature. 2002 Apr 11;416(6881):648-53 - PubMed
  90. Cell Death Dis. 2014 Jan 23;5:e1013 - PubMed
  91. Mol Carcinog. 2004 Jan;39(1):26-33 - PubMed
  92. Biochemistry. 1975 May 20;14(10):2214-8 - PubMed
  93. J Biol Chem. 2003 May 23;278(21):18811-6 - PubMed
  94. Mol Cell Biol. 2000 Mar;20(5):1886-96 - PubMed
  95. Nat Med. 2014 Nov;20(11):1242-53 - PubMed
  96. Genetics. 2006 Jul;173(3):1301-17 - PubMed
  97. Carcinogenesis. 2002 Oct;23(10):1695-9 - PubMed
  98. Proc Natl Acad Sci U S A. 2008 Mar 11;105(10 ):3933-8 - PubMed
  99. Int J Biol Sci. 2012;8(8):1168-77 - PubMed
  100. Int J Oncol. 2002 Sep;21(3):597-601 - PubMed
  101. Oncogene. 2013 Sep 26;32(39):4721-6 - PubMed
  102. Nucleic Acids Res. 2013 Feb 1;41(3):1698-710 - PubMed
  103. Mol Cell. 2008 Jan 18;29(1):69-80 - PubMed
  104. Nature. 2002 Sep 12;419(6903):135-41 - PubMed
  105. Cell Cycle. 2011 Jun 15;10 (12 ):1912-5 - PubMed
  106. Nature. 2011 Mar 3;471(7336):110-4 - PubMed
  107. Nat Rev Mol Cell Biol. 2010 Mar;11(3):196-207 - PubMed
  108. Nucleic Acids Res. 2005 Oct 13;33(18):5878-86 - PubMed
  109. Nat Rev Cancer. 2003 Mar;3(3):155-68 - PubMed
  110. Haematologica. 2010 Sep;95(9):1510-8 - PubMed
  111. Cancer Res. 2010 Nov 1;70(21):8264-9 - PubMed
  112. Cell Cycle. 2004 Apr;3(4):419-21 - PubMed
  113. Mol Carcinog. 2005 Aug;43(4):237-45 - PubMed
  114. Mol Cell Biol. 2006 Sep;26(17 ):6502-10 - PubMed
  115. FEBS J. 2010 Mar;277(5):1319-30 - PubMed
  116. Cell. 2003 Mar 21;112(6):779-91 - PubMed
  117. Cell. 2007 Nov 30;131(5):887-900 - PubMed
  118. J Biol Chem. 2011 Aug 12;286(32):28599-607 - PubMed
  119. Cell. 1992 Jun 26;69(7):1237-45 - PubMed
  120. EMBO J. 2011 Nov 15;30(24):4921-30 - PubMed
  121. DNA Cell Biol. 2001 Jun;20(6):321-30 - PubMed
  122. Cell Death Differ. 2012 Sep;19(9):1424-34 - PubMed
  123. Mol Cell. 2009 Jan 16;33(1):109-16 - PubMed
  124. Nat Rev Mol Cell Biol. 2010 Sep;11(9):621-32 - PubMed
  125. Cell. 1995 Jan 27;80(2):293-9 - PubMed
  126. Nature. 2010 Jan 7;463(7277):103-7 - PubMed
  127. Trends Biochem Sci. 2005 Apr;30(4):183-7 - PubMed
  128. Science. 2004 Feb 6;303(5659):844-8 - PubMed
  129. Nat Struct Mol Biol. 2011 Jun 26;18(7):761-8 - PubMed
  130. Science. 2006 Aug 25;313(5790):1122-6 - PubMed
  131. Cell. 1993 Nov 5;75(3):495-505 - PubMed
  132. EMBO J. 2000 Jan 4;19(1):94-102 - PubMed
  133. EMBO J. 1998 Oct 15;17(20):5964-73 - PubMed
  134. Cell Growth Differ. 1998 Jan;9(1):79-84 - PubMed
  135. EMBO J. 2009 Oct 21;28(20):3207-15 - PubMed
  136. J Biol Chem. 1999 Dec 31;274(53):37538-43 - PubMed
  137. Nat Rev Cancer. 2013 Jul;13(7):443-54 - PubMed
  138. Nucleic Acids Res. 2012 Jan;40(1):196-205 - PubMed
  139. PLoS One. 2013 Dec 18;8(12 ):e82803 - PubMed
  140. Cell Signal. 2013 Nov;25(11):2320-33 - PubMed
  141. Cell Cycle. 2010 Feb 1;9(3):472-8 - PubMed
  142. Mol Cell. 2013 Mar 7;49(5):795-807 - PubMed
  143. Oncogene. 2002 Apr 4;21(15):2328-33 - PubMed
  144. Genes Dev. 2013 May 15;27(10 ):1101-14 - PubMed
  145. Cell Rep. 2013 Mar 28;3(3):881-91 - PubMed
  146. EMBO J. 2007 Jul 11;26(13):3062-74 - PubMed
  147. Cell Cycle. 2004 Jun;3(6):689-92 - PubMed
  148. Proc Natl Acad Sci U S A. 2005 Apr 5;102(14 ):5056-61 - PubMed
  149. Cell. 2005 Jul 1;121(7):1071-83 - PubMed
  150. Annu Rev Biochem. 2001;70:503-33 - PubMed
  151. Eur J Surg Oncol. 2013 Jan;39(1):100-6 - PubMed
  152. Cell Cycle. 2008 Nov 1;7(21):3399-404 - PubMed
  153. J Clin Oncol. 2005 Jun 10;23 (17 ):3886-96 - PubMed
  154. Nat Rev Cancer. 2002 Sep;2(9):647-56 - PubMed
  155. Prog Clin Biol Res. 1985;180:17-31 - PubMed
  156. Nat Genet. 2010 Sep;42(9):755-8 - PubMed
  157. Cell Death Dis. 2013 May 30;4:e647 - PubMed
  158. Cancer Cell. 2007 Oct;12 (4):342-54 - PubMed
  159. Mol Cell. 2012 Aug 24;47(4):497-510 - PubMed
  160. Cell. 2007 Aug 24;130(4):597-600 - PubMed
  161. Trends Cell Biol. 2012 Sep;22(9):483-91 - PubMed
  162. BMC Cancer. 2014 Jun 14;14:437 - PubMed
  163. EMBO J. 2010 Jul 21;29(14):2407-20 - PubMed
  164. Cancer Sci. 2009 May;100(5):866-72 - PubMed
  165. Nature. 2011 Mar 3;471(7336):104-9 - PubMed
  166. Oncogene. 2005 Mar 3;24(10):1663-72 - PubMed
  167. Cell Cycle. 2007 Sep 15;6(18):2205-9 - PubMed
  168. Mol Cell. 2004 Mar 26;13(6):879-86 - PubMed
  169. EMBO J. 2012 Feb 1;31(3):576-92 - PubMed
  170. Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1888-93 - PubMed
  171. Cell Cycle. 2012 Feb 15;11(4):749-60 - PubMed
  172. Mol Cell Biochem. 2014 May;390(1-2):93-100 - PubMed
  173. EMBO J. 2005 Oct 5;24(19):3353-9 - PubMed
  174. Chromosoma. 2011 Feb;120(1):1-21 - PubMed
  175. Lung Cancer. 2004 Mar;43(3):285-95 - PubMed
  176. Nat Biotechnol. 2003 Aug;21(8):921-6 - PubMed
  177. Cancer Res. 2005 Jul 15;65(14):6282-93 - PubMed
  178. Oncogene. 2010 Jan 21;29(3):432-41 - PubMed
  179. Oncogene. 2007 Feb 26;26(9):1324-37 - PubMed
  180. Cell. 1998 Aug 21;94(4):481-90 - PubMed
  181. Annu Rev Biochem. 2012;81:203-29 - PubMed
  182. Nucleic Acids Res. 2013 Feb 1;41(3):1750-6 - PubMed
  183. J Immunol. 2001 Mar 1;166(5):3130-42 - PubMed
  184. Clin Cancer Res. 2010 Jun 1;16(11):2949-58 - PubMed
  185. J Cell Biol. 2007 Dec 31;179(7):1453-66 - PubMed
  186. Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2351-6 - PubMed
  187. Mol Cancer Res. 2011 Dec;9(12 ):1780-90 - PubMed
  188. Cell. 2009 Feb 6;136(3):435-46 - PubMed
  189. Cell. 2005 Dec 2;123(5):773-86 - PubMed
  190. Oncogene. 2004 Apr 12;23(16):2797-808 - PubMed
  191. Mol Pharm. 2013 Sep 3;10 (9):3375-83 - PubMed
  192. Nat Cell Biol. 2011 Oct 23;13(11):1376-82 - PubMed
  193. Nat Struct Mol Biol. 2012 Jan 22;19(2):201-6 - PubMed
  194. J Natl Cancer Inst. 2004 Nov 17;96(22):1718-21 - PubMed
  195. J Clin Invest. 2014 Feb;124(2):835-46 - PubMed
  196. J Biol Chem. 2006 Nov 10;281(45):34124-34 - PubMed
  197. Biochem Biophys Res Commun. 2011 Sep 30;413(3):460-4 - PubMed
  198. J Biol Chem. 2001 Aug 17;276(33):31357-67 - PubMed
  199. Cancer Res. 2009 Aug 1;69(15):6115-21 - PubMed
  200. J Biol Chem. 2004 Mar 19;279(12 ):11696-704 - PubMed
  201. Cancer Res. 2003 Dec 15;63(24):8606-13 - PubMed
  202. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3244-8 - PubMed
  203. Br J Cancer. 2013 Jun 25;108(12 ):2495-504 - PubMed
  204. Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16275-80 - PubMed
  205. J Biol Chem. 2003 Sep 12;278(37):34743-6 - PubMed
  206. Science. 1998 Aug 28;281(5381):1322-6 - PubMed

Publication Types

Grant support